James Investment Research’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-108
Closed -$22K – 562
2023
Q1
$22K Buy
+108
New +$17.3K ﹤0.01% 434
2020
Q3
– Sell
-625
Closed -$106K – 521
2020
Q2
$106K Hold
625
– – 0.01% 275
2020
Q1
$72K Hold
625
– – 0.01% 280
2019
Q4
$71K Buy
+625
New +$66.3K ﹤0.01% 356

Other funds holding SGEN

James Investment Research's SGEN Position: Q2 2023 in Review

James Investment Research sold out of Seagen Inc. Common Stock (SGEN) in Q2 2023, closing a stake of 108 shares — an estimated $22K sold.

James Investment Research first reported a position in SGEN in Q4 2019 and held it in 4 quarters. The position peaked at $106K in Q2 2020. 594 funds tracked by Wall St. Rank hold SGEN as of Q2 2023.

  • James Investment Research reported no remaining Seagen Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • James Investment Research sold 108 Seagen Inc. Common Stock shares in Q2 2023, an estimated $22K.
  • James Investment Research first reported a position in Seagen Inc. Common Stock in Q4 2019 and held it in 4 quarters.
  • James Investment Research's Seagen Inc. Common Stock position peaked at $106K in Q2 2020.
  • 594 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q2 2023.

Based on James Investment Research's 13F filing for Q2 2023, filed 7 Aug 2023.